JP2024529015A5 - - Google Patents
Info
- Publication number
- JP2024529015A5 JP2024529015A5 JP2024506857A JP2024506857A JP2024529015A5 JP 2024529015 A5 JP2024529015 A5 JP 2024529015A5 JP 2024506857 A JP2024506857 A JP 2024506857A JP 2024506857 A JP2024506857 A JP 2024506857A JP 2024529015 A5 JP2024529015 A5 JP 2024529015A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- skeleton
- population
- retroviral
- viral vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163228972P | 2021-08-03 | 2021-08-03 | |
| US63/228,972 | 2021-08-03 | ||
| PCT/GB2022/052039 WO2023012475A1 (en) | 2021-08-03 | 2022-08-03 | Engineering of gamma delta t cells and compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529015A JP2024529015A (ja) | 2024-08-01 |
| JP2024529015A5 true JP2024529015A5 (enExample) | 2025-08-15 |
Family
ID=83005850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506857A Pending JP2024529015A (ja) | 2021-08-03 | 2022-08-03 | ガンマデルタｔ細胞及びその組成物の操作 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240344024A1 (enExample) |
| EP (1) | EP4381075A1 (enExample) |
| JP (1) | JP2024529015A (enExample) |
| KR (1) | KR20240040799A (enExample) |
| CN (1) | CN117795083A (enExample) |
| AR (1) | AR126690A1 (enExample) |
| AU (1) | AU2022322052A1 (enExample) |
| CA (1) | CA3228168A1 (enExample) |
| CO (1) | CO2024002241A2 (enExample) |
| MX (1) | MX2024001657A (enExample) |
| TW (1) | TW202328434A (enExample) |
| WO (1) | WO2023012475A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20242341A1 (es) | 2022-04-04 | 2024-12-12 | Gammadelta Therapeutics Ltd | Blindaje genetico novedoso |
| CN119020418B (zh) * | 2024-08-17 | 2025-06-13 | 广东君厚生物医药有限公司 | BaEV逆转录病毒载体的包装方法及其包装细胞系 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
| US6136597A (en) | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
| EP1777294A1 (en) | 2005-10-20 | 2007-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins |
| EP2710123B1 (en) | 2011-05-19 | 2017-07-12 | Instituto de Medicina Molecular | Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof |
| JP6799895B2 (ja) | 2015-06-09 | 2020-12-16 | リンファクト−リンフォサイト アクティベイション テクノロジーズ エス．エー． | ＴＣＲγδ＋Ｔ細胞の生産方法 |
| CN108473958A (zh) | 2015-10-30 | 2018-08-31 | 癌症研究技术有限公司 | 非造血组织驻留γδT细胞的扩增及这些细胞的用途 |
| EP4467146A3 (en) * | 2017-09-15 | 2025-05-07 | King's College London | Compositions and methods for enhancing gamma delta t cells in the gut |
| DE102017127984B4 (de) * | 2017-11-27 | 2019-12-05 | Immatics US, Inc. | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen |
| WO2020021045A2 (en) * | 2018-07-26 | 2020-01-30 | Ospedale Pediatrico Bambino Gesù (Opbg) | Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufacture and use |
| KR20210111746A (ko) | 2018-11-08 | 2021-09-13 | 감마델타 테라퓨틱스 리미티드 | 세포를 단리 및 증식하는 방법 |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
-
2022
- 2022-08-03 CA CA3228168A patent/CA3228168A1/en active Pending
- 2022-08-03 KR KR1020247006876A patent/KR20240040799A/ko active Pending
- 2022-08-03 WO PCT/GB2022/052039 patent/WO2023012475A1/en not_active Ceased
- 2022-08-03 TW TW111129165A patent/TW202328434A/zh unknown
- 2022-08-03 JP JP2024506857A patent/JP2024529015A/ja active Pending
- 2022-08-03 US US18/294,659 patent/US20240344024A1/en active Pending
- 2022-08-03 CN CN202280053433.6A patent/CN117795083A/zh active Pending
- 2022-08-03 MX MX2024001657A patent/MX2024001657A/es unknown
- 2022-08-03 EP EP22757990.1A patent/EP4381075A1/en active Pending
- 2022-08-03 AR ARP220102077A patent/AR126690A1/es unknown
- 2022-08-03 AU AU2022322052A patent/AU2022322052A1/en active Pending
-
2024
- 2024-02-26 CO CONC2024/0002241A patent/CO2024002241A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102423444B1 (ko) | 레트로바이러스 벡터 | |
| Ferreira et al. | Progress and perspectives in the development of lentiviral vector producer cells | |
| Sakuma et al. | Lentiviral vectors: basic to translational | |
| CN100443593C (zh) | 用病毒载体稳定转导细胞的方法 | |
| Ni et al. | Generation of a packaging cell line for prolonged large‐scale production of high‐titer HIV‐1‐based lentiviral vector | |
| JP7098521B2 (ja) | レトロウイルス産生のための安定な細胞株 | |
| Poeschla et al. | CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells | |
| Negre et al. | Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells | |
| Kobayashi et al. | Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus | |
| RU2749717C2 (ru) | Способ временной трансфекции для продуцирования ретровируса | |
| JP6975643B2 (ja) | レンチウイルスベクターのバイオ生産法 | |
| JP2018534937A5 (enExample) | ||
| CA2456169A1 (en) | Methods and compositions relating to improved lentiviral vector production systems | |
| JP2019500030A5 (enExample) | ||
| JP2024045128A5 (enExample) | ||
| US20260055146A1 (en) | Delivery of heterologous proteins | |
| JP2023526348A5 (enExample) | ||
| Mikkola et al. | Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells | |
| WO2021232633A1 (zh) | 启动元件及包含其的逆转录病毒基因组转录盒和载体 | |
| US11993782B2 (en) | Lentivirus packaging system, lentivirus produced by the same, cell transduced by the lentivirus, method for improving lentivirus production in a host cell, and method of using the cell for treating cancer | |
| JP6629210B2 (ja) | エンベロープウイルスの産生方法 | |
| Gropp et al. | Lentiviral vector–mediated gene delivery into human embryonic stem cells | |
| CA2484166A1 (en) | Improved chimeric glycoproteins and pseudotyped lentiviral vectors | |
| US20250230511A1 (en) | Methods and reagents for amplifying viral vector nucleic acid products | |
| Olgun et al. | High-titer production of HIV-based lentiviral vectors in roller bottles for gene and cell therapy |